Browsing by Subject "Efficacy endpoints"
Now showing items 1-2 of 2
-
Effect of performance status on efficacy endpoints in phase II trials of non-small cell lung cancer
(Brac University, 2023-12)Researchers must prioritize non-small cell lung cancer clinical research due of its high mortality. Ongoing endeavors are being made to improve the accessibility, evaluation simplicity, and prediction accuracy of endpoints ... -
Efficacy analysis of tyrosine kinase inhibitor combinations in phase II clinical trials of non-small cell lung cancer
(Brac University, 2023-01)Research is required in the area of non-small cell lung cancer, due to its widespread prevalence. Efforts to enhance the accessibility, evaluative simplicity, and prediction accuracy of endpoints in clinical trials are ...
